Skip to content

A randomized controlled trial for three-dimensional visualization in choice of percutaneous access of puncture percutaneous nephrolithotripsy for treatment of renal stone

A randomized controlled trial for three-dimensional visualization in choice of percutaneous access of puncture percutaneous nephrolithotripsy for treatment of renal stone

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057122
Enrollment
Unknown
Registered
2022-02-28
Start date
2024-02-15
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal calculus

Interventions

experimental group:3D visualization technology

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-85 years; 2. Patients with kidney stones (> 2 cm) confirmed by preoperative imaging examination; 3. Patients agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Renal calculi with abnormal anatomical structure (horseshoe kidney, ureteropelrus junction stenosis, solitary kidney, ectopic kidney, etc.); 2. Patients with uncontrolled urinary tract infection and sepsis; 3. Patients with multiple underlying diseases who cannot tolerate surgery; 4. Any other conditions that the investigator deemed inappropriate for participation in the trial.

Design outcomes

Primary

MeasureTime frame
stone free rate;operation time;intraoperative blood loss;postoperative hemoglobin;channel selection;postoperative serum creatinine;surgical approach;glomerular filtration rate;age;gender;the channel size;indwelling time of fistula tube;

Countries

China

Contacts

Public ContactCheng Jiwen

The First Affiliated Hospital of Guangxi Medical University

chengjiwen1977@foxmail.com+86 135 9711 1198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026